Latest database descriptions

The primary objective of the study is to verify the absence of accumulation of bismuth in subjects prescribed Pylera®, a pharmacokinetic approach in a real-life setting.

I-VISCONTI is a multicenter, multidisciplinary (clinicians, virologists, immunologists and epidemiologists) pathophysiologic study designed to explore the virological and immunological mechanisms responsible for sustained control of HIV-1 infection after ART interruption in adults or children who started treatment very early in the primary infection or during the chronic phase. I-VISCONTI also aims to identify markers that could be used to identify patients who could reasonably interrupt their antiretroviral treatment.

study the family determinants (genetic and environmental) of cardiovascular risk indicators and/or factors by using the model of the nuclear family. The 2 aspects, cross-sectional and longitudinal, are broached through specific designs.

General objective: to study MS treatment modalities and determinants. To move towards a greater representation of patient population with multiple sclerosis as defined by geographical criteria.